Activity of combined androgen receptor antagonism and cell cycle inhibition in androgen receptor-positive triple-negative breast cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype, with a peak recurrence rate within the first few years post diagnosis. Few targeted therapies are available to treat this breast cancer (BC) subtype, defined by the lack of estrogen and progesterone receptors (ER and PR) and without ampl...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Cancer Ther
Main Authors: Christenson, Jessica L., O’Neill, Kathleen I., Williams, Michelle M., Spoelstra, Nicole S., Jones, Kenneth L., Trahan, G. Devon, Reese, Jordan, Van Patten, Elaina T, Elias, Anthony, Eisner, Joel R., Richer, Jennifer K.
Format: Artigo
Sprog:Inglês
Udgivet: 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8172456/
https://ncbi.nlm.nih.gov/pubmed/33722849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0807
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker